Phase Forward Revenue Jumps 30%

Wednesday, July 30, 2008 09:07 AM

Waltham, Mass.-based Phase Forward, a provider of data management solutions for clinical trials and drug safety, reported after the bell Monday a 30% jump in second quarter revenues to $40.9 million from $31.5 million in the second quarter of 2007.

Bob Weiler, CEO and president of Phase Forward, said, "During the quarter, we signed noteworthy deals with both new and existing customers across the range of our target markets. We are particularly pleased with the continued success of our CRO [contract research organization] Advantage Program during the quarter, as evidenced by winning new CRO customers and deepening our relationships with a number of existing strategic CRO partners."

For the second quarter of 2008, income from operations was $4.2 million, compared with $3.2 million in the second quarter of 2007. For the second quarter of 2008, income from operations was $6.4 million, a 42% rise from the prior year period and an operating margin of 15.7%.

Phase Forward's shares closed down 1.6% at $18.37 on Tuesday.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs